Shoulder Innovations, Inc.
NYSE:SIMedical - Specialties
-$0.13 today
- Market cap
- $432.04M
- Beta
- -1.07
- P/E (TTM)
- -8.4
- EPS (TTM)
- -$2.13
Volume 0.09M
Average 0.10M
SI Accounts Payables
Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.
Shoulder Innovations, Inc.NYSE: SI
Accounts Payables · Q1 FY2026 · quarter ended Mar 2026
Accounts payables grows 51.7% year over year
Q1 FY2026 accounts payables of $3.22M (cash outflow) rose 51.7% year over year.
Context
- Accounts payables amounted to 7.1% of revenue in FY2025, down 2.8 pp from a year earlier.
- Accounts payables increased in 2 of the last 2 fiscal years.
- FY2025 was the highest annual figure in the 3 fiscal years shown.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Payables history
USD · from the cash flow
- Latest · FY2025
- 3.37M USD
- Year-over-year change
- +7.8%
| Period | Period end | Accounts Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 3.37M | +7.8% |
| FY2024 | 2024-12-31 | 3.12M | +523.9% |
| FY2023 | 2023-12-31 | (737K) | — |
Accounts Payables vs competitors
How SI compares with its peers on the latest reported figures
- SI's LTM Mar 2026 accounts payables of $2.27M is the 3rd largest of the 11 companies compared; the peer median is $325.49K.
- Accounts payables amounts to 4.2% of revenue for SI, versus a peer median of 0.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
EPRXEupraxia Pharmaceuticals Inc. | LTM Mar 2026 | $3.31M | +280.1% | +21.9% | — |
| LTM Mar 2026 | $2.63M | -232.5% | -6.1% | 0.7% | |
| LTM Mar 2026 | $2.27M | — | — | 4.2% | |
| LTM Mar 2026 | $2.01M | +6.4% | +97.6% | — | |
| LTM Mar 2026 | $890K | +150.0% | -41.1% | 2.0% | |
| FY2025 | $550K | — | — | 0.5% | |
| LTM Mar 2026 | $399K | +1230.0% | -34.4% | 0.6% | |
| LTM Mar 2026 | $344K | +108.3% | +37.0% | 0.3% | |
| LTM Dec 2025 | $306.99K | +123.6% | -15.0% | 2.4% | |
| LTM Mar 2026 | $262K | +132.6% | -50.3% | — | |
| LTM Mar 2026 | $254K | +71.6% | — | 0.4% | |
| Peer median (excluding SI) | $325.49K | +123.6% | -10.5% | 0.6% | |
Competitors are the stored peer set for SI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|
| Net Income | (12.66M) | (15.62M) | (40.36M) |
| Depreciation & Amortization | 1.64M | 2.2M | 3.21M |
| Deferred Income Tax | 0 | 0 | 0 |
| Stock-Based Compensation | 451K | 754K | 996K |
| Change in Working Capital | (4.77M) | (1.04M) | 0 |
| Accounts Receivables | (2.69M) | (575K) | (3.3M) |
| Inventory | (2.41M) | (4.03M) | (7.64M) |
| Accounts Payables | (737K) | 3.12M | 3.37M |
| Other Working Capital | 1.08M | 446K | 0 |
| Other Non-Cash Items | 2.18M | (437K) | 7.54M |
| Operating Cash Flow | (13.14M) | (14.14M) | (28.61M) |
| Capital Expenditures | (2.75M) | (4.02M) | (7.41M) |
| Acquisitions (Net) | 0 | 0 | 0 |
| Purchases of Investments | (29.25M) | (5.28M) | (119.49M) |
| Sales of Investments | 3.03M | 23.26M | 31.3M |
| Other Investing Activities | 0 | 0 | 0 |
| Investing Cash Flow | (28.97M) | 13.96M | (95.6M) |
| Debt Repayment | 10M | 0 | 0 |
| Common Stock Issued | 34.88M | 66K | 39.51M |
| Common Stock Repurchased | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 |
| Other Financing Activities | (149K) | 66K | 144.96M |
| Financing Cash Flow | 44.73M | 66K | 144.96M |
| Effect of Forex Changes | 0 | 0 | 0 |
| Net Change in Cash | 2.61M | (113K) | 20.75M |
| Free Cash Flow | (15.89M) | (18.16M) | (36.02M) |
Shoulder Innovations, Inc.
NYSE:SI
Intrinsic Alpha fair value
Locked
Current Price
$20.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.